Impact of Lipid Composition and Receptor Conformation on the Spatio-temporal Organization of μ-Opioid Receptors in a Multi-component Plasma Membrane Model

PLoS Computational Biology

Volumn 12, Issue 12, 2016, Pages

  Marino, Kristen A ^a   Prada Gracia, Diego ^a   Provasi, Davide ^a   Filizola, Marta ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COARSE-GRAINED MODELING; CONFORMATIONS; CYTOLOGY; MAMMALS; MOLECULAR DYNAMICS; OLIGOMERIZATION; OLIGOMERS; PHOSPHOLIPIDS; PROTEINS;

BULK PROPERTIES; CLASS A; G PROTEIN COUPLED RECEPTORS; LIPID COMPOSITION; MEMBRANE MODELS; MEMBRANE PROTEINS; MULTICOMPONENTS; OLIGOMERIZATIONS; OPIOID RECEPTORS; SPATIO-TEMPORAL ORGANIZATION;

CELL MEMBRANES;

DIMER; MEMBRANE PROTEIN; MU OPIATE RECEPTOR; SPHINGOMYELIN; LIPID;

ALPHA HELIX; ARTICLE; CELL MEMBRANE; CRYSTAL STRUCTURE; DIMERIZATION; LIPID BILAYER; LIPID COMPOSITION; MEMBRANE MODEL; MOLECULAR DYNAMICS; OLIGOMERIZATION; PROTEIN CONFORMATION; RECEPTOR DENSITY; SIMULATION; ANIMAL; CHEMISTRY; LIPID METABOLISM; METABOLISM; MOLECULAR MODEL; MOUSE; PHYSIOLOGY;

ANIMALS; CELL MEMBRANE; LIPID METABOLISM; LIPIDS; MICE; MODELS, MOLECULAR; RECEPTORS, OPIOID, MU;

EID: 85007591199     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1005240     Document Type: Article

References (80)

1. Gimpl G, Fahrenholz F, Cholesterol as stabilizer of the oxytocin receptor. Biochim Biophys Acta—Biomembr. 2002;1564: 384–392.
2. Hanson MA, Cherezov V, Griffith MT, Roth CB, Jaakola VP, Chien EYT, et al. A specific cholesterol binding site is established by the 2.8 Å structure of the human β2-adrenergic receptor. Structure. 2008;16: 897–905. doi: 10.1016/j.str.2008.05.00118547522
3. Gimpl G, Burger K, Fahrenholz F, Cholesterol as modulator of receptor function. Biochemistry. 1997;36: 10959–10974. doi: 10.1021/bi963138w9283088
4. Pucadyil TJ, Chattopadhyay A, Cholesterol modulates ligand binding and G-protein coupling to serotonin1A receptors from bovine hippocampus. Biochim Biophys Acta—Biomembr. 2004;1663: 188–200.
5. Zheng Pearsall, Hurst Zhang, Chu Zhou, et al. Palmitoylation and membrane cholesterol stabilize μ-opioid receptor homodimerization and G protein coupling. BMC Cell Biol. 2012;13: 6. doi: 10.1186/1471-2121-13-622429589
6. Prasanna X, Chattopadhyay A, Sengupta D, Cholesterol modulates the dimer interface of the β2-adrenergic receptor via cholesterol occupancy sites. Biophys J. Elsevier; 2014;106: 1290–1300.
7. Oates J, Faust B, Attrill H, Harding P, Orwick M, Watts A, The role of cholesterol on the activity and stability of neurotensin receptor 1. Biochim Biophys Acta—Biomembr. 2012;1818: 2228–2233.
8. Paila YD, Kombrabail M, Krishnamoorthy G, Chattopadhyay A, Oligomerization of the serotonin 1A receptor in live cells: A time-resolved fluorescence anisotropy approach. J Phys Chem B. 2011;115: 11439–11447. doi: 10.1021/jp201458h21866959
9. Gibson NJ, Brown MF, Lipid headgroup and acyl chain composition modulate the MI-MI1 equilibrium of rhodopsin in recombinant membranes. Biochemistry. 1993;32: 2438–2454. 8443184
10. Dawaliby R, Trubbia C, Delporte C, Masureel M, Van Antwerpen P, Kobilka BK, et al. Allosteric regulation of G protein–coupled receptor activity by phospholipids. Nat Chem Biol. 2016;12: 35–41. doi: 10.1038/nchembio.196026571351
11. Inagaki S, Ghirlando R, White JF, Gvozdenovic-Jeremic J, Northup JK, Grisshammer R, Modulation of the interaction between neurotensin receptor NTS1 and Gq protein by lipid. J Mol Biol. 2012;417: 95–111. doi: 10.1016/j.jmb.2012.01.02322306739
12. Killian JA, Hydrophobic mismatch between proteins and lipids in membranes. Biochim Biophys Acta—Rev Biomembr. 1998;1376: 401–415.
13. Lingwood D, Simons K, Lipid rafts as a membrane-organizing principle. Science. 2010;327: 46–50. doi: 10.1126/science.117462120044567
14. Sonnino S, Prinetti A, Membrane domains and the “lipid raft” concept. Curr Med Chem. 2013;20: 4–21. 23150999
15. Liu W, Chun E, Thompson AA, Chubukov P, Xu F, Katritch V, et al. Structural basis for allosteric regulation of GPCRs by sodium ions. Science. 2012;337: 232–6. doi: 10.1126/science.121921822798613
16. Jafurulla M, Chattopadhyay A, Membrane lipids in the function of serotonin and adrenergic receptors. Curr Med Chem. 2013;20: 47–55. 23151002
17. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SGF, Thian FS, Kobilka TS, et al. High-resolution crystal structure of an engineered human β2-adrenergic G-protein couped receptor. Science. 2007;318: 1258–1266. doi: 10.1126/science.115057717962520
18. Wu H, Wang C, Gregory KJ, Han GW, Cho HP, Xia Y, et al. Structure of a class C GPCR metabotropic glutamate receptor 1 bound to an allosteric modulator. Science. 2014;344: 58–64. doi: 10.1126/science.124948924603153
19. Periole X, Huber T, Marrink S, Sakmar TP, G protein-coupled receptors self-assemble in dynamics simulations of model bilayers. J Am Chem Soc. 2007;129: 10126–10132. doi: 10.1021/ja070624617658882
20. Soubias O, Teague WE, Hines KG, Mitchell DC, Gawrisch K, Contribution of membrane elastic energy to rhodopsin function. Biophys J. Biophysical Society; 2010;99: 817–824.
21. Pitman MC, Grossfield A, Suits F, Feller SE, Role of cholesterol and polyunsaturated chains in lipid − protein interactions: Molecular dynamics simulation of rhodopsin in a realistic membrane environment. Biochim Biophys Acta. 2005; 4576–4577.
22. Grossfield A, Feller SE, Pitman MC, A role for direct interactions in the modulation of rhodopsin by omega-3 polyunsaturated lipids. Proc Natl Acad Sci U S A. 2006;103: 4888–4893. doi: 10.1073/pnas.050835210316547139
23. Lee JY, Patel R, Lyman E, Ligand-dependent cholesterol interactions with the human A2A adenosine receptor. Chem Phys Lipids. Elsevier Ireland Ltd; 2013;169: 39–45. doi: 10.1016/j.chemphyslip.2013.02.00223454349
24. Khelashvili G, Grossfield A, Feller SE, Pitman MC, Weinstein H, Structural and dynamic effects of cholesterol at preferred sites of interaction with rhodopsin identified from microsecond length molecular dynamics simulations. Proteins Struct Funct Bioinforma. 2009;76: 403–417.
25. Sengupta D, Chattopadhyay A, Identification of Cholesterol Binding Sites in the Serotonin1A Receptor. J Phys Chem B. 2012;116: 12991–12996. doi: 10.1021/jp309888u23067252
26. Lyman E, Higgs C, Kim B, Lupyan D, Shelley JC, Farid R, et al. A role for a specific cholesterol interaction in stabilizing the apo configuration of the human A2A adenosine receptor. Structure. Elsevier Ltd; 2009;17: 1660–1668.
27. Ingólfsson HI, Melo MN, Eerden FJ Van, Arnarez C, López CA, Wassenaar TA, et al. Lipid organization of the plasma membrane. J Am Chem Soc. 2014;136: 14554–14559. doi: 10.1021/ja507832e25229711
28. Provasi D, Boz MB, Johnston JM, Filizola M, Preferred supramolecular organization and dimer interfaces of opioid receptors from simulated self-association. PLoS Comput Biol. 2015;11: 1–21.
29. Manglik A, Kruse AC, Kobilka TS, Thian FS, Mathiesen JM, Sunahara RK, et al. Crystal structure of the μ-opioid receptor bound to a morphinan antagonist. Nature. 2012;485: 321–326. doi: 10.1038/nature1095422437502
30. Huang W, Manglik A, Venkatakrishnan AJ, Laeremans T, Feinberg EN, Sanborn AL, et al. Structural insights into μ-opioid receptor activation. Nature. 2015;524: 315–21. doi: 10.1038/nature1488626245379
31. Gomes I, Fujita W, Gupta A, Saldanha SA, Negri A, Pinello CE, et al. Identification of a μ-δ opioid receptor heteromer-biased agonist with antinociceptice activity. Proc Natl Acad Sci U S A. 2013;110: 12072–12077. doi: 10.1073/pnas.122204411023818586
32. Zheng H, Chu J, Qiu Y, Loh HH, Law P- Y, Agonist-selective signaling is determined by the receptor location within the membrane domains. Proc Natl Acad Sci U S A. 2008;105: 9421–9426. doi: 10.1073/pnas.080225310518599439
33. Moulédous L, Merker S, Neasta J, Roux B, Zajac JM, Mollereau C, Neuropeptide FF-sensitive confinement of mu opioid receptor does not involve lipid rafts in SH-SY5Y cells. Biochem Biophys Res Commun. 2008;373: 80–84. doi: 10.1016/j.bbrc.2008.05.17418544342
34. Halls ML, Yeatman HR, Nowell CJ, Thompson G, Gondin AB, Civciristov S, et al. Plasma membrane localization of the mu-opioid receptor controls spatiotemporal signaling. Sci Signal. 2016;9: ra16. doi: 10.1126/scisignal.aac917726861044
35. Gaibelet G, Millot C, Lebrun C, Ravault S, Sauliere A, Andre A, et al. Cholesterol content drives distinct pharmacological behaviours of μ-opioid receptor in different microdomains of the CHO plasma membrane. Mol Membr Biol. 2008;25: 423–435. doi: 10.1080/0968768080220338018651319
36. Qiu Y, Wang Y, Law P, Chen H, Loh HH, Cholesterol regulates μ-opioid receptor-induced β-Arrestin 2 translocation to membrane lipid rafts. Mol Pharmacol. 2011;80: 210–218. doi: 10.1124/mol.110.07087021518774
37. Gu R, Ingólfsson HI, Vries AH De, Marrink SJ, Tieleman DP, Ganglioside-lipid and ganglioside-protein interactions revealed by coarse-grained and atomistic molecular dynamics simulations. J Phys Chem B. 2016; in press.
38. Hamilton JA, Fast flip-flop of cholesterol and fatty acids in membranes: implications for membrane transport proteins. Curr Opin Lipidol. 2003;14: 263–271. doi: 10.1097/01.mol.0000073507.41685.9b12840657
39. Niemelä PS, Miettinen MS, Monticelli L, Hammaren H, Bjelkmar P, Murtola T, et al. Membrane proteins diffuse as dynamic complexes with lipids. J Am Chem Soc. 2010;132: 7574–7575. doi: 10.1021/ja101481b20469857
40. Koldsø H, Sansom MSP, Organization and dynamics of receptor proteins in a plasma membrane. J Am Chem Soc. 2015;137: 14694–14704. doi: 10.1021/jacs.5b0804826517394
41. Guixà-González R, Javanainen M, Gómez-Soler M, Cordobilla B, Domingo JC, Sanz F, et al. Membrane omega-3 fatty acids modulate the oligomerisation kinetics of adenosine A2A and dopamine D2 receptors. Sci Rep. 2016;6: 19839. doi: 10.1038/srep1983926796668
42. Periole Knepp, Sakmar Marrink, Huber. Structural determinants of the supramolecular organization of g protein-coupled receptors in bilayers. J Am Chem Soc. 2012;134: 10959–10965. doi: 10.1021/ja303286e22679925
43. Holdbrook DA, Huber RG, Piggot TJ, Bond PJ, Khalid S, Dynamics of crowded vesicles: Local and global responses to membrane composition. PLoS One. 2016;11: e0156963. doi: 10.1371/journal.pone.015696327310814
44. Mondal S, Johnston JM, Wang H, Khelashvili G, Filizola M, Weinstein H, Membrane driven spatial organization of GPCRs. Sci Rep. 2013;3: 2909. doi: 10.1038/srep0290924105260
45. Sengupta D, Chattopadhyay A, Molecular dynamics simulations of GPCR–cholesterol interaction: An emerging paradigm. Biochim Biophys Acta—Biomembr. 2015;1848: 1775–1782.
46. Katira S, Mandadapu KK, Vaikuntanathan S, Smit B, Chandler D, Pre-transition effects mediate forces of assembly between transmembrane proteins. Elife. 2016;5: e13150. doi: 10.7554/eLife.1315026910009
47. van Meer G, Voelker DR, Feigenson GW, Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol. 2008;9: 112–124. doi: 10.1038/nrm233018216768
48. Simons K, Toomre D, Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000;1: 31–39. doi: 10.1038/3503605211413487
49. Ostrom RS, Insel PA, The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology. Br J Pharmacol. 2004;143: 235–45. doi: 10.1038/sj.bjp.070593015289291
50. Goren MA, Morizumi T, Menon I, Joseph JS, Dittman JS, Cherezov V, et al. Constitutive phospholipid scramblase activity of a G protein-coupled receptor. Nat Commun. 2014;5: 1–10.
51. Bennett WFD, MacCallum JL, Tieleman DP, Thermodynamic analysis of the effect of cholesterol on dipalmitoylphosphatidylcholine lipid membranes. J Am Chem Soc. 2009;131: 1972–1978. doi: 10.1021/ja808541r19146400
52. Harroun TA, Katsaras J, Wassall SR, Cholesterol is found to reside in the center of a polyunsaturated lipid membrane. Biochemistry. 2008;47: 7090–7096. doi: 10.1021/bi800123b18543943
53. Marrink SJ, De Vries AH, Harroun TA, Katsaras J, Wassall SR, Cholesterol shows preference for the interior of polyunsaturated lipid membranes. J Am Chem Soc. 2008;130: 10–11. doi: 10.1021/ja076641c18076174
54. Jo S, Rui H, Lim JB, Klauda JB, Im W, Cholesterol flip-flop: Insights from free energy simulation studies. J Phys Chem B. 2010;114: 13342–13348. doi: 10.1021/jp108166k20923227
55. Choubey A, Kalia RK, Malmstadt N, Nakano A, Vashishta P, Cholesterol translocation in a phospholipid membrane. Biophys J. 2013;104: 2429–2436. doi: 10.1016/j.bpj.2013.04.03623746515
56. Neale C, Herce HD, Pomès R, García AE, Can specific protein-lipid interactions stabilize an active state of the beta 2 adrenergic receptor?Biophys J. 2015;109: 1652–1662. doi: 10.1016/j.bpj.2015.08.02826488656
57. Logothetis DE, Petrou VI, Zhang M, Mahajan R, Meng X-Y, Adney SK, et al. Phosphoinositide control of membrane protein function: A frontier led by studies on ion channels. Annu Rev Physiol. 2015;77: 81–104. doi: 10.1146/annurev-physiol-021113-17035825293526
58. Mancia F, Assur Z, Herman AG, Siegel R, Hendrickson WA, Ligand sensitivity in dimeric associations of the serotonin 5HT2c receptor. EMBO Rep. 2008;9: 363–9. doi: 10.1038/embor.2008.2718344975
59. Guo W, Shi L, Filizola M, Weinstein H, Javitch JA, Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation. Proc Natl Acad Sci U S A. 2005;102: 17495–17500. doi: 10.1073/pnas.050895010216301531
60. Xue L, Rovira X, Scholler P, Zhao H, Liu J, Pin J-P, et al. Major ligand-induced rearrangement of the heptahelical domain interface in a GPCR dimer. Nat Chem Biol. ing Group; 2015;11: 134–140.
61. Fenalti G, Giguere PM, Katritch V, Huang X-P, Thompson AA, Cherezov V, et al. Molecular control of δ-opioid receptor signalling. Nature. 2014;506: 191–196. doi: 10.1038/nature1294424413399
62. Huang J, Chen S, Zhang JJ, Huang X-Y, Crystal structure of oligomeric β1-adrenergic G protein-coupled receptors in ligand-free basal state. Nat Struct Mol Biol. 2013;20: 419–25. doi: 10.1038/nsmb.250423435379
63. Wu B, Chien EYT, Mol CD, Fenalti G, Liu W, Katritch V, et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science. 2010;330: 1066–1071. doi: 10.1126/science.119439620929726
64. Tan Q, Zhu Y, Li J, Chen Z, Han GW, Kufareva I, et al. Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex. Science. 2013;341: 1387–1390. doi: 10.1126/science.124147524030490
65. Parsadaniantz SM, Rostene W, Goazigo ARL, Opioid and chemokine receptor crosstalk: a promising target for pain therapy?Nat Rev Neurosci. 2015;16: 69–78. doi: 10.1038/nrn385825588373
66. Sali A, Blundell TL, Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol. 1993;234: 779–815. doi: 10.1006/jmbi.1993.16268254673
67. Marrink S, Vries A De, Mark A, Coarse grained model for semiquantitative lipid simulations. J Phys Chem B. 2004;108: 750–760.
68. Monticelli L, Kandasamy SK, Periole X, Larson RG, Tieleman DP, Marrink SJ, The MARTINI coarse grained force field: extension to proteins. J Chem Theory Comput. 2008;4: 819–834. doi: 10.1021/ct700324x26621095
69. Marrink SJ, Risselada HJ, Yefimov S, Tieleman DP, Vries AH De, The MARTINI force field: Coarse grained model for biomolecular simulations. J Phys Chem B. 2007;111: 7812–7824. doi: 10.1021/jp071097f17569554
70. Periole X, Cavalli M, Marrink SJ, Ceruso MA, Combining an elastic network with a coarse-grained molecular force field: Structure, dynamics, and intermolecular recognition. J Chem Theory Comput. 2009;5: 2531–2543. doi: 10.1021/ct900211426616630
71. Provasi D, Johnston JM, Filizola M, Lessons from free energy simulations of δ-opioid receptor homodimers involving the fourth transmembrane helix. Biochemistry. 2010;49: 6771–6776. doi: 10.1021/bi100686t20617813
72. Ballesteros J, Weinstein H, Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein coupled receptors. Methods Neurosci. 1995;25: 366–428.
73. Wassenaar TA, Ingólfsson HI, Böckmann RA, Tieleman DP, Marrink SJ, Computational lipidomics with insane: A versatile tool for generating custom membranes for molecular simulations. J Chem Theory Comput. 2015;11: 2144–2155. doi: 10.1021/acs.jctc.5b0020926574417
74. Bussi G, Donadio D, Parrinello M, Canonical sampling through velocity rescaling. J Chem Phys. 2007;126: 14101.
75. Berensen HJC, Postma JPM, van Gunsteren WF, DiNola A, Haak JR, Molecular dynamics with coupling to an external bath. J Chem Phys. 1984;81: 3684–3690.
76. Pronk S, Páll S, Schulz R, Larsson P, Bjelkmar P, Apostolov R, et al. GROMACS 4.5: A high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics. 2013;29: 845–54. doi: 10.1093/bioinformatics/btt05523407358
77. Hess B, Kutzner C, Spoel D Van Der, Lindahl E, GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput. 2008;4: 435–447. doi: 10.1021/ct700301q26620784
78. Scherer MK, Trendelkamp-Schroer B, Paul F, Pérez-Hernández G, Hoffmann M, Plattner N, et al. PyEMMA 2: A software package for estimation, validation, and analysis of markov models. J Chem Theory Comput. 2015;11: 5525–5542. doi: 10.1021/acs.jctc.5b0074326574340
79. Gelman A, Lee D, Guo J, Stan: A Probabilistic Programming Language for Bayesian Inference and Optimization. J Educ Behav Stat. 2015;40: 530–543.
80. Michaud-Agrawal N, Denning EJ, Woolf TB, Beckstein O, MDAnalysis: A toolkit for the analysis of molecular dynamics simulations. J Comput Chem. 2011;32: 2319–2327. doi: 10.1002/jcc.2178721500218